AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10999119 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH study in Group 1 (29 patients) with normal TSH response to TRH
Number of subjects: 82
Study 10999119 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH study in Group 2 (20 patients) with normal baseline TSH and exaggerated TSH response to TRH
Number of subjects: 82
Study 10999119 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH study in Group 3 (18 patients) with baseline TSH 5 to 10 mu IU/ml and exaggerated TSH response to TRH
Number of subjects: 82
Study 10999119 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 subjects)
Number of subjects: 82
Study 7743572 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (225 micrograms.kg‐1)
Number of subjects: 0
Study 7743572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium (65 micrograms.kg‐1)
Number of subjects: 0
Study 7743572 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium (300 micrograms.kg‐1)
Number of subjects: 0
Study 7743572 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (40 micrograms.kg‐1)
Number of subjects: 0
Study 2139387 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium dobesilate
Number of subjects: 40
Study 2139387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6113074 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam (30 to 80 mg/day)
Number of subjects: 159
Study 6113074 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (15 to 40 mg/day)
Number of subjects: 159
Study 6113074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 31764972 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 ratio
Number of subjects: 150
Study 31764972 — intervention group
Group type: EXPERIMENTAL
Intervention: %LGE
Number of subjects: 150
Study 31764972 — intervention group
Group type: EXPERIMENTAL
Intervention: SAnCtUS score (score = 4)
Number of subjects: 150
Study 31764972 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined endpoint (sustained ventricular tachycardia and sudden cardiac death)
Number of subjects: 150
Study 31102650 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal film containing microdoses of midazolam (30 μg)
Number of subjects: 12
Study 31102650 — intervention group
Group type: COMPARATOR
Intervention: Buccal solution of midazolam
Number of subjects: 12
Study 28683981 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 19
Study 28683981 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 19
Study 28683981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 26495770 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow titration of sertraline
Number of subjects: 56
Study 26495770 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular titration of sertraline
Number of subjects: 56
Study 26495770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 23756309 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational videotaped message (intervention group)
Number of subjects: 415
Study 23756309 — intervention group
Group type: COMPARATOR
Intervention: Brochure (control group)
Number of subjects: 415
Study 21978770 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial protein substitute (TPS) with a carbohydrate/protein-equivalent ratio of 0.5:1
Number of subjects: 14
Study 21978770 — intervention group
Group type: COMPARATOR
Intervention: Control protein substitute (CPS) with a carbohydrate/protein-equivalent ratio of 1:1
Number of subjects: 14
Study 19050625 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance by a rapid response system team or cardiac arrest team
Number of subjects: 741744
Study 16534036 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on performance
Number of subjects: 345
Study 16534036 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback plus reminders
Number of subjects: 345
Study 16534036 — intervention group
Group type: COMPARATOR
Intervention: Reminders alone
Number of subjects: 345
Study 16534036 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 345
Study 12724111 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 27
Study 12724111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 11023139 — intervention group
Group type: EXPERIMENTAL
Intervention: linoleic acid diet
Number of subjects: 11
Study 11023139 — intervention group
Group type: COMPARATOR
Intervention: oleic acid diet
Number of subjects: 11
Study 9279219 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized glutathione (GSH) 600 mg with 4 ml of 0.9% sodium chloride
Number of subjects: 8
Study 9279219 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical saline solution)
Number of subjects: 8
Study 8286805 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin 2% vaginal cream
Number of subjects: 215
Study 8286805 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 215
Study 3268179 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (0.1 mg/Kg)
Number of subjects: 180
Study 3268179 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine (1.5 mg/Kg)
Number of subjects: 180
Study 3268179 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of morphine and meperidine
Number of subjects: 180
Study 29482033 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + BA + CM
Number of subjects: 92
Study 29482033 — intervention group
Group type: COMPARATOR
Intervention: CBT + BA
Number of subjects: 92
Study 29482033 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotinine
Number of subjects: 92
Study 29482033 — intervention group
Group type: EXPERIMENTAL
Intervention: In-treatment cotinine decreases
Number of subjects: 92
Study 27185681 — intervention group
Group type: EXPERIMENTAL
Intervention: Video‐Mac VL
Number of subjects: 121
Study 27185681 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope VL
Number of subjects: 121
Study 27185681 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath VL
Number of subjects: 121
Study 27185681 — intervention group
Group type: EXPERIMENTAL
Intervention: All three VL devices
Number of subjects: 121
Study 27185681 — intervention group
Group type: EXPERIMENTAL
Intervention: Video‐Mac VL and McGrath VL
Number of subjects: 121
Study 27185681 — intervention group
Group type: EXPERIMENTAL
Intervention: Video‐Mac VL and GlideScope VL
Number of subjects: 121
Study 27185681 — intervention group
Group type: COMPARATOR
Intervention: Standard Direct Laryngoscopy (DL)
Number of subjects: 121
Study 25149616 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 241
Study 25149616 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 241
Study 25149616 — intervention group
Group type: EXPERIMENTAL
Intervention: Both laparoscopic and open appendectomy
Number of subjects: 241
Study 23824727 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC 20:1n-9
Number of subjects: 2000
Study 23824727 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC 22:1n-9
Number of subjects: 2000
Study 23824727 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC cis 18:1n-9
Number of subjects: 2000
Study 23824727 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC 24:1n-9
Number of subjects: 2000
Study 21162515 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension band wire
Number of subjects: 65
Study 21162515 — intervention group
Group type: COMPARATOR
Intervention: Hook plate
Number of subjects: 65
Study 20467650 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded implants
Number of subjects: 30
Study 20467650 — intervention group
Group type: COMPARATOR
Intervention: Early loaded implants
Number of subjects: 30
Study 20467650 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 15302735 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive LDL cholesterol lowering
Number of subjects: 852
Study 15302735 — intervention group
Group type: COMPARATOR
Intervention: Moderate LDL cholesterol lowering
Number of subjects: 852
Study 15302735 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose warfarin
Number of subjects: 852
Study 15302735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 852
Study 11239659 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (1 mg) injected intra-amniotically 24 hours before the procedure
Number of subjects: 126
Study 11239659 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) injected intra-amniotically 24 hours before the procedure
Number of subjects: 126
Study 11239659 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (1 mg)
Number of subjects: 126
Study 9663724 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (RBC) 400 mg b.d. for 28 days plus clarithromycin 500 mg b.d. for 7 days (Group A)
Number of subjects: 112
Study 9663724 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (RBC) 400 mg b.d. for 28 days plus clarithromycin 500 mg b.d. for 14 days (Group B)
Number of subjects: 112
Study 7819689 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids only (14 patients, 63.6%)
Number of subjects: 92
Study 7819689 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids and high-dose gamma globulin (4 patients)
Number of subjects: 92
Study 7819689 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids and splenectomy (2 patients)
Number of subjects: 92
Study 7819689 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids and immunosuppressive therapy (2 patients)
Number of subjects: 92
Study 7819689 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial prednisone course (1-5 mg/kg/day)
Number of subjects: 92
Study 7819689 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment (4 patients, 18.2%)
Number of subjects: 92
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg/day
Number of subjects: 500
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg/day
Number of subjects: 500
Study 2978324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg/day
Number of subjects: 500
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg/day
Number of subjects: 500
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 500
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 500
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg/day
Number of subjects: 500
Study 2978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Pizotifen 1.5 mg/day
Number of subjects: 500
Study 30895678 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized poly-ether-ether-ketone (PEEK) mesh
Number of subjects: 16
Study 30895678 — intervention group
Group type: COMPARATOR
Intervention: Prebent titanium mesh (Control group)
Number of subjects: 16
Study 28285932 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf raise exercise
Number of subjects: 29
Study 28285932 — intervention group
Group type: COMPARATOR
Intervention: Walking exercise
Number of subjects: 29
Study 25561075 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG‐BF (Electromyography Biofeedback) during maximal voluntary isometric contractions (MVICs)
Number of subjects: 15
Study 25561075 — intervention group
Group type: COMPARATOR
Intervention: Control condition (MVICs without EMG‐BF)
Number of subjects: 15
Study 22364109 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental contrasting condition (fantasising about positive outcomes of losing weight and contrasting these fantasies with obstacles)
Number of subjects: 64
Study 22364109 — intervention group
Group type: COMPARATOR
Intervention: Positive indulging condition (fantasising about positive outcomes of losing weight)
Number of subjects: 64
Study 21923923 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (Q)
Number of subjects: 29
Study 18679165 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (3.4 +/- 1.1 mL/d)
Number of subjects: 83
Study 18679165 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 83
Study 18679165 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk or infant formula (control)
Number of subjects: 83
Study 17063405 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese version of Lam Assessment of Stages of Employment Readiness (LASER)
Number of subjects: 90
Study 12554998 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic lymphadenectomy
Number of subjects: 80
Study 12554998 — intervention group
Group type: COMPARATOR
Intervention: Classic lymphadenectomy
Number of subjects: 80
Study 12554998 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study 10867086 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Protocol (MP)
Number of subjects: 80
Study 10867086 — intervention group
Group type: COMPARATOR
Intervention: Traditional Protocol (TP)
Number of subjects: 80
Study 9352964 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab bolus and infusion
Number of subjects: 101
Study 9352964 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab bolus
Number of subjects: 101
Study 9352964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 9352964 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 101
Study 8245085 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (n = 25)
Number of subjects: 66
Study 8245085 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (n = 31)
Number of subjects: 66
Study 8245085 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment for undisplaced fractures (n = 10)
Number of subjects: 66
Study 3545844 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin twice daily (60 mg/kg per day for 10 days)
Number of subjects: 110
Study 3545844 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin thrice daily (60 mg/kg per day for 10 days)
Number of subjects: 110
Study 3545844 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin twice daily
Number of subjects: 110
Study 3545844 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin thrice daily
Number of subjects: 110
Study 3545844 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin twice daily and thrice daily
Number of subjects: 110
Study 30448267 — intervention group
Group type: EXPERIMENTAL
Intervention: Education-plus-values-clarification version of the decision aid
Number of subjects: 1000
Study 30448267 — intervention group
Group type: COMPARATOR
Intervention: Education-only version of the decision aid
Number of subjects: 1000
Study 30794972 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-layer duraplasty
Number of subjects: 123
Study 30794972 — intervention group
Group type: COMPARATOR
Intervention: Single-layer duraplasty
Number of subjects: 123
Study 29728142 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler
Number of subjects: 2684
Study 29728142 — intervention group
Group type: COMPARATOR
Intervention: Fetoscope
Number of subjects: 2684
Study 27224235 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-based iterative reconstruction (MBIR)
Number of subjects: 56
Study 25441408 — intervention group
Group type: EXPERIMENTAL
Intervention: Afatinib (40 mg/day, increasing to 50 mg/day if minimal toxicity)
Number of subjects: 50
Study 25441408 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 loading dose, then 250 mg/m2/week)
Number of subjects: 50
Study 25441408 — intervention group
Group type: EXPERIMENTAL
Intervention: Afatinib in KRAS-mutated group
Number of subjects: 50
Study 22507365 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential laser therapy (n=100)
Number of subjects: 200
Study 22507365 — intervention group
Group type: COMPARATOR
Intervention: Conventional laser therapy (n=100)
Number of subjects: 200
Study 20480136 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) for 3 days
Number of subjects: 67
Study 20480136 — intervention group
Group type: COMPARATOR
Intervention: Oxygen alone for 3 days
Number of subjects: 67
Study 17513190 — intervention group
Group type: EXPERIMENTAL
Intervention: Active gel (lidocaine 20 mg/g)
Number of subjects: 40
Study 17513190 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 40
Study 14967173 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise (5000 steps at 180 steps/min)
Number of subjects: 24
Study 14967173 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle intensity exercise (5000 steps at 130 steps/min)
Number of subjects: 24
Study 14967173 — intervention group
Group type: COMPARATOR
Intervention: Low intensity exercise (5000 steps at 80 steps/min)
Number of subjects: 24
Study 11779600 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst transfer
Number of subjects: 162
Study 11779600 — intervention group
Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 162
Study 9689289 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% aqueous sodium lauryl sulfate (SLS)
Number of subjects: 0
Study 9689289 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study 7863833 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate, 20 mg/day for 6 months
Number of subjects: 30
Study 7863833 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 30
Study 2923740 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 125
Study 2923740 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediastinoscopy
Number of subjects: 125
Study 30989655 — intervention group
Group type: EXPERIMENTAL
Intervention: REBACIN®
Number of subjects: 199
Study 30989655 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 199
Study 29119864 — intervention group
Group type: EXPERIMENTAL
Intervention: Having an informal caregiver
Number of subjects: 253
Study 29119864 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support score
Number of subjects: 253
Study 29119864 — intervention group
Group type: EXPERIMENTAL
Intervention: Having an informal caregiver with social support included
Number of subjects: 253
Study 25256207 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D audiovisual distraction (3D video glasses)
Number of subjects: 90
Study 25256207 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio distraction (music)
Number of subjects: 90
Study 25256207 — intervention group
Group type: COMPARATOR
Intervention: Control group (basic behaviour guidance techniques without distraction)
Number of subjects: 90
Study 23257278 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement during learning
Number of subjects: 0
Study 23257278 — intervention group
Group type: COMPARATOR
Intervention: Observation based TI task
Number of subjects: 0
Study 23257278 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep after a 12-hour delay
Number of subjects: 0
Study 23257278 — intervention group
Group type: COMPARATOR
Intervention: Wake after a 12-hour delay
Number of subjects: 0
Study 21812261 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Granule (BHG)
Number of subjects: 94
Study 21812261 — intervention group
Group type: EXPERIMENTAL
Intervention: Madopar (basic treatment) + BHG
Number of subjects: 94
Study 21812261 — intervention group
Group type: COMPARATOR
Intervention: Madopar (basic treatment) + Placebo
Number of subjects: 94
Study 18521097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold caloric vestibular stimulation
Number of subjects: 1
Study 18521097 — intervention group
Group type: COMPARATOR
Intervention: Placebo procedures
Number of subjects: 1
Study 16487224 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 mg daily for 6 days
Number of subjects: 21
Study 16487224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 12966817 — intervention group
Group type: EXPERIMENTAL
Intervention: Manually guided exposure therapy in virtual environments
Number of subjects: 0
Study 12966817 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition (control group)
Number of subjects: 0
Study 16627796 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular red cell transfusion
Number of subjects: 0
Study 16627796 — intervention group
Group type: COMPARATOR
Intervention: Episodic or no transfusion
Number of subjects: 0
Study 10588226 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI nonadherence for one week
Number of subjects: 39
Study 10588226 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI adherence for one week
Number of subjects: 39
Study 10588226 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial adherence for one week
Number of subjects: 39
Study 10588226 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma AcSDKP
Number of subjects: 39
Study 10588226 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine AcSDKP
Number of subjects: 39
Study 10588226 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ACE
Number of subjects: 39
Study 8570252 — intervention group
Group type: EXPERIMENTAL
Intervention: Canalith repositioning procedure
Number of subjects: 60
Study 8570252 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular habituation exercises
Number of subjects: 60
Study 8570252 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 1929099 — intervention group
Group type: EXPERIMENTAL
Intervention: Estriol vaginal cream
Number of subjects: 80
Study 1929099 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone and Estriol vaginal cream
Number of subjects: 80
Study 1929099 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 80
Study 1929099 — intervention group
Group type: EXPERIMENTAL
Intervention: Veralipride
Number of subjects: 80
Study 7124323 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 2
Study 7124323 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 2
Study 27339446 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 70
Study 27339446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70